Balis, Marjorie M.

HRN: 27-03-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/12/2025
09/18/2025
IV
500mg
Q8
Appendicitis
Remove - Pending Acceptance
09/12/2025
CEFTRIAXONE 1G (VIAL)
09/12/2025
09/18/2025
IV
2gm
OD
Appendicitis
Remove - Pending Acceptance
09/12/2025
MUPIROCIN 2%, 15G (TUBE)
09/12/2025
09/19/2025
TOPICAL
2%
BID
S/P Exlap Appendectomy
Remove - Pending Acceptance
09/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/14/2025
09/24/2025
IV
4.5g
Q6HRS
T/C ILEOCECAL ADENOCARCINOMA
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: